Taipei Exchange - Delayed Quote TWD

Meribank Biotech Co., Ltd (4724.TWO)

Compare
14.80
-0.25
(-1.66%)
At close: 2:59:45 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
366,430
366,430
234,342
180,120
163,076
Cost of Revenue
172,489
172,489
95,472
85,350
73,020
Gross Profit
193,941
193,941
138,870
94,770
90,056
Operating Expense
280,614
280,614
257,384
205,143
181,992
Operating Income
-86,673
-86,673
-118,514
-110,373
-91,936
Net Non Operating Interest Income Expense
-8,169
-8,169
1,008
283
-648
Pretax Income
-101,548
-101,548
-129,946
-103,227
-99,192
Tax Provision
-4,612
-4,612
-441
-81
--
Net Income Common Stockholders
-94,711
-94,711
-125,346
-102,134
-99,192
Diluted NI Available to Com Stockholders
-94,711
-94,711
-125,346
-102,134
-99,192
Basic EPS
-1.19
--
-1.99
-1.63
-1.63
Diluted EPS
-1.19
--
-1.99
-1.63
-1.63
Basic Average Shares
79,589.08
--
62,987.94
63,178
60,984
Diluted Average Shares
95,676.41
--
62,987.94
63,178
60,984
Total Expenses
453,103
453,103
352,856
290,493
255,012
Net Income from Continuing & Discontinued Operation
-94,711
-94,711
-125,346
-102,134
-99,192
Normalized Income
-93,537.82
-93,537.82
-120,721.75
-102,723.54
-93,910
Interest Income
2,529
2,529
1,855
1,268
478
Interest Expense
10,698
10,698
847
985
1,126
Net Interest Income
-8,169
-8,169
1,008
283
-648
EBIT
-90,850
-90,850
-129,099
-102,242
-98,066
EBITDA
-6,827
-6,827
-92,563
-70,078
-68,598
Reconciled Cost of Revenue
172,489
172,489
95,472
85,350
73,020
Reconciled Depreciation
84,023
84,023
36,536
32,164
29,468
Net Income from Continuing Operation Net Minority Interest
-94,711
-94,711
-125,346
-102,134
-99,192
Total Unusual Items Excluding Goodwill
-1,229
-1,229
-4,640
590
-5,282
Total Unusual Items
-1,229
-1,229
-4,640
590
-5,282
Normalized EBITDA
-5,598
-5,598
-87,923
-70,668
-63,316
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
-55.82
-55.82
-15.75
0.46
--
12/31/2021 - 6/16/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4197.TWO Visgeneer Inc.
10.05
0.00%
 
6704.TWO Gwo Xi Stem Cell Applied Technology Co. , Ltd
22.10
-1.78%
 
4169.TWO TCM Biotech International Corp.
52.50
-0.76%
 
6652.TWO Eusol Biotech Co.,Ltd.
6.19
+2.15%
 
4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.
13.50
+2.27%
 
4732.TWO NatureWise Biotech & Medicals Corporation
19.65
-1.01%
 
7607.TWO DuoGenic StemCells corporation
15.00
+0.33%
 
4178.TWO StemCyte International, Ltd.
28.45
-1.90%
 
6586.TWO CHO Pharma, Inc.
44.00
-3.19%
 
4194.TWO Holy Stone Healthcare Co., Ltd.
7.17
-5.03%